Total Debt for Abbott Laboratories (ABT)
According to Abbott Laboratories's latest reported financial statements, the company's latest reported total debt is $15.07B USD. Total debt is the sum of short-term and long-term interest-bearing borrowings on the balance sheet (notes, bonds, term loans, lease liabilities). Useful for leverage and refinancing risk — combine with cash on hand for net debt, and see total liabilities for the broader obligations picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingTotal DebtSwitch metric
Latest period
$15.07B
YoY change
-1.4%
5Y CAGR
-5.4%
Peak year (2017)
$27.92B
Latest annual
$15.07B
Total Debt history chart for Abbott Laboratories (ABT) from 1985 to 2025
Total Debt history table for Abbott Laboratories (ABT) from 1985 to 2025
| Fiscal year | Period ended | Reported | Total Debt | YoY |
|---|---|---|---|---|
| 2025 | $15.07B | -1.4% | ||
| 2024 | $15.28B | -3.8% | ||
| 2023 | $15.87B | -11.6% | ||
| 2022 | $17.95B | -6.8% | ||
| 2021 | $19.25B | -3.2% | ||
| 2020 | $19.89B | +4.1% | ||
| 2019 | $19.10B | -2.4% | ||
| 2018 | $19.57B | -29.9% | ||
| 2017 | $27.92B | +26.9% | ||
| 2016 | $22.01B | +144.5% | ||
| 2015 | $9.00B | +15.0% | ||
| 2014 | $7.83B | +19.3% | ||
| 2013 | $6.56B | -68.0% | ||
| 2012 | $20.48B | +32.8% | ||
| 2011 | $15.41B | -18.5% | ||
| 2010 | $18.92B | +15.0% | ||
| 2009 | $16.46B | +43.8% | ||
| 2008 | $11.45B | -6.3% | ||
| 2007 | $12.21B | -1.6% | ||
| 2006 | $12.41B | +87.1% | ||
| 2005 | $6.63B | -2.2% | ||
| 2004 | $6.78B | +13.2% | ||
| 2003 | $5.99B | -6.7% | ||
| 2002 | $6.42B | -11.9% | ||
| 2001 | $7.29B | +368.5% | ||
| 2000 | $1.56B | -30.3% | ||
| 1999 | $2.23B | -27.9% | ||
| 1998 | $3.10B | +14.0% | ||
| 1997 | $2.72B | +17.4% | ||
| 1996 | $2.32B | +56.0% | ||
| 1995 | $1.49B | +40.2% | ||
| 1994 | $1.06B | -7.9% | ||
| 1993 | $1.15B | +12.1% | ||
| 1992 | $1.03B | +53.3% | ||
| 1991 | $669.40M | -16.2% | ||
| 1990 | $798.60M | +78.6% | ||
| 1989 | $447.20M | -46.9% | ||
| 1988 | $842.60M | -4.0% | ||
| 1987 | $877.40M | -1.3% | ||
| 1986 | $889.10M | +57.1% | ||
| 1985 | $565.90M | — |
Total Debt values are taken from Abbott Laboratories's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
The 2025 reading of Abbott Laboratories (ABT) total debt is $15.07B – edged down 1.4% year-over-year.
Abbott Laboratories total debt has contracted on net over the period, with a -5.4% compound annual growth rate over 2020–2025 (5 years).
The dataset's maximum total debt sits at $27.92B (2017); the minimum reading of $447.20M dates to 1989.
Among 8 Healthcare peers, Abbott Laboratories (ABT) ranks 9th; the peer median for total debt is $52.57B.
Abbott Laboratories Total Debt by Year
Abbott Laboratories Total Debt 2025: $15.07B
Abbott Laboratories total debt in 2025 was $15.07B, edged down 1.4% below 2024.
Abbott Laboratories Total Debt 2024: $15.28B
Abbott Laboratories total debt in 2024 was $15.28B, edged down 3.8% below 2023.
Abbott Laboratories Total Debt 2023: $15.87B
Abbott Laboratories total debt in 2023 was $15.87B, declined 11.6% below 2022.
Abbott Laboratories Total Debt 2022: $17.95B
Abbott Laboratories total debt in 2022 was $17.95B, declined 6.8% below 2021.
Abbott Laboratories Total Debt 2021: $19.25B
Abbott Laboratories total debt in 2021 was $19.25B.
See more financial history for Abbott Laboratories (ABT).
Sector peers — Total Debt
Companies in the same sector as Abbott Laboratories, ranked by their latest total debt.
| Company | Total Debt | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $130.96B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $78.39B | Healthcare |
| AbbVie Inc. (ABBV) | $69.07B | Healthcare |
| Amgen Inc. (AMGN) | $54.60B | Healthcare |
| Merck & Co., Inc. (MRK) | $50.53B | Healthcare |
| Johnson & Johnson (JNJ) | $47.93B | Healthcare |
| Eli Lilly and Company (LLY) | $42.50B | Healthcare |
| AstraZeneca PLC (AZN) | $29.70B | Healthcare |
Frequently asked questions
What is Abbott Laboratories's total debt?
- Latest reported total debt for Abbott Laboratories (ABT) is $15.07B (period ending December 31, 2025).
How has Abbott Laboratories total debt changed year-over-year?
- Abbott Laboratories (ABT) total debt changed -1.4% year-over-year on the latest annual filing.
What is the long-term growth rate of Abbott Laboratories total debt?
- Abbott Laboratories (ABT) total debt compound annual growth rate is -5.4% over the most recent 5 years available.
When did Abbott Laboratories total debt hit its highest annual value?
- Abbott Laboratories total debt reached its highest annual value of $27.92B in 2017.
What was Abbott Laboratories total debt in 2024?
- Abbott Laboratories (ABT) total debt in 2024 was $15.28B.
What was Abbott Laboratories total debt in 2025?
- Abbott Laboratories (ABT) total debt in 2025 was $15.07B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
ABT Overview
Company profile, financial tools, and key metrics
ABT Revenue Counter
Earns $1,431 every second. See per minute, hour, and day.
ABT Earnings Counter
Earns $199.01 per second net profit. See per minute, hour, and day.
ABT Economic Scale
Exceeds Paraguay's GDP. Compare with world economies.
ABT What If Invested
What if you had invested $1,000? See historical returns from any date.
ABT How It Makes Money
Discover visual breakdown of $45.13B in revenue — where it comes from and where it goes.
ABT Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
ABT Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
ABT Daily Price Character
Steady · 48.2% historical win rate (green days). Streaks & record days.
ABT Buybacks
0.41% TTM buyback yield. Shareholder yield & SBC comparison.
ABT Stock Split History
9 splits on record. Dates, ratios, and cumulative multiple.
ABT Dividend Profile
Yield: 2.67%. Safety: 6/8. See full history.
ABT Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
ABT Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.